维普中文期刊产品整合服务
27篇 您的检索式:作者名="Gene M B"
    题名 作者 年代 出处 被引量
1The Relation Between NOx Emissions and Precipitation NO3-in the Eastern USA显示文摘Thomas J B Gene L Francoise M 2003Atmospheric Environment2003,37,:1
2显示文摘Rahman M McVetty P B E,Li G Y,Development of SRAP1SNP and multiplexed SCAR molecular markers for the major seed coat color gene in Brassica rapa L 2007Theoretical and Applied Genetics2007,115,8:1
3Economic growth and the en- vironment 显示文摘Grossman Gene M Krueger Alan B 1995Quarterly Journal of Economics1995,,11:1
4Purification and properties of L-Aspartate-alpha-decarboxylase,an enzyme that catalyzes the formation of beta-alanine in Escherichia coli 显示文摘Joanne M W Gene M B 1979J Biol Chem1979,254,:1
5Economic Growth and the Environment显示文摘Gene M G Alan B K 1995Quarterly Journal of Economics1995,110,6:1
6Production of multiple shootS from thidiazuron-treated mature embryos and leaf-base/apical meristems of barley ( Horon vulgate ) 显示文摘Genes hen S Baga M Harvey B L 2003Plant Cell Tiss Org Cult2003,73,:1
7A gut-specific regulation of chitin content of peritrophic matrix and growth of Ostrinia nubilalis larvae 显示文摘CHITVAN K LAWRENT L B chitinase gene essential for CHEN M S 2010Insect Biochemistry and Molecular Biology2010,40,8:1
8Economic growth and the environment显示文摘Gene M G Alan B K 1995Quarterly Journal of Economics1995,110,:1
9cluster, M-CSF genes, on human chromosome 5显示文摘van Leeuwen B H Martinson M E Webb G Molecular organization of the cytokine involving the human IL-3 IL-4 IL-5 and G gene C 1989Blood1989,73,5:1
10Identification of the of Escherichia coli MG1655 and characterization of its Product显示文摘Thaller M C Sehippa S Bonei A gene(aPhA)encoding thee lass B acid 1997FEMS Microbiol Lett1997,146,:1
11The relation between NOx emissions and precipitation NO3 in the eastern USA 显示文摘Thomas J B Gene L Francoise M 2003Atmos Environ2003,37,:1
12and enteroinvasive escherichia coli 显示文摘Buysse J M Hartman A B Strockbine N Genetic polymorphism of the ipaH multicopy antigen gene in shigella spps 1995Microb Pathog1995,19,:1
13Economics growth and the enviroment显示文摘Gene M Grossman Alan B Krueger 1995The Quarterly Journal of Economics1995,110,2:1
14Economic growth and the environment显示文摘Grossman Gene M Alan B Krueger 1995Quarterly Journal of Economics1995,110,2:1
15mycoides Small Colony(MmmSC)by using phage display显示文摘Dubravka R Miltiadoul Arshad Matherl Edy M Vilei2 and Dian H Du Plessis Identification of genes coding for B cell antigens of Mycoplasma mycoides subsp 2009BMC Microbiology2009,9,:1
16Nef in cholesterol synthesis and upvirus type 1-infected T cells显示文摘VAN'T WOUT A B SWAIN J induces multiple genes involved take in human immunodeficiency V SCHINDLER M 2005J Virol2005,79,10:1
17Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
18Economic Growth and the Environment 显示文摘Gene M Grossman Alan B Krueger 1995The Quarterly Journal of Economics1995,110,2:1
19Economic growth and the environment显示文摘Gene M Grossman Alan B Krueger 1995Quarterly Journal of Economics1995,110,2:1
20Dilute acid pretreatment, enzy- matic saccharification and fermentation of wheat straw to ethanol 显示文摘gene Plant Saha B C hen L B Cotta M A 2005Process Biochemistry2005,40,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费